{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:01:07Z","timestamp":1760043667923},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/mjt.0000000000000003","type":"journal-article","created":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T10:57:21Z","timestamp":1387882641000},"page":"e304-e306","source":"Crossref","is-referenced-by-count":9,"title":["Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus"],"prefix":"10.1097","volume":"23","author":[{"given":"Sumedh S.","family":"Hoskote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narender","family":"Annapureddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul K.","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-49-20210202","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1468-1331.2008.02527.x","article-title":". Valacyclovir neurotoxicity: clinical experience and review of the literature.","volume":"16","author":"Asahi","year":"2009","journal-title":"Eur J Neurol"},{"key":"R2-49-20210202","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00007611-199412000-00006","article-title":"Acyclovir neurotoxicity: clinical experience and review of the literature.","volume":"87","author":"Adair","year":"1994","journal-title":"South Med J"},{"key":"R3-49-20210202","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ndt\/gfg119","article-title":". High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study.","volume":"18","author":"Hellden","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R4-49-20210202","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":". A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R5-49-20210202","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1351-5101.2003.00719.x","article-title":"Neurotoxicity of acyclovir and valacyclovir in a hemodialyzed patient.","volume":"11","author":"Strumia","year":"2004","journal-title":"Eur J Neurol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0000000000000003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:23:58Z","timestamp":1620962638000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201601000-00049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0000000000000003","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}